Verity Pharmaceuticals Inc.
$293.4K 4,640 recipients
Compare payment profiles
CMS Open Payments · Program Year 2024
IlluminOss Medical, Inc.
IlluminOss Medical, Inc. reported $293,677.78 across General Payments, Research, and Ownership to 469 physicians and teaching hospitals across 486 transactions.
- $293.7K
- All-tracks total
- 486
- Transactions
- 469
- Recipients
- +$20.6K
- General Payments vs PY2023
IlluminOss Medical, Inc. reported $293,677.78 across all CMS Open Payments tracks (General + Research + Ownership) to 469 physicians and teaching hospitals in Program Year 2024 - ranking #894 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $168,851.78, averaging $626.18 per recipient.
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer illuminoss-medical-inc IlluminOss Medical, Inc.
$293.7K · #894/1,925 · 0.0% industry · PY2024
- TOT $293.7K
- RANK #894
- SHARE 0.0%
- TXN 486
- RCP 469
- CAT 5
- GEN $168.9K
- ΔGEN +$20.6K
- TOP1 17.6%
- PY 2024
Volume peers
Nearest volume peer: Verity Pharmaceuticals Inc. ($293.4K)
IlluminOss Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
Release-over-release change
General Payments changed from PY2023 to PY2024
IlluminOss Medical, Inc.'s CMS-reported General Payments increased by $20.6K (+13.9%) from PY2023 to PY2024.
How this year-over-year comparison is scoped
The comparison uses consecutive CMS program years only (current = prior + 1) from the manufacturer General Payments summary and excludes research and ownership or investment records. Non-consecutive year pairs are not shown as year-over-year change. This General Payments figure is not the all-tracks company total in the hero.
CMS source labels for this exact identifier: PY2022: ILLUMINOSS MEDICAL, INC.PY2023: ILLUMINOSS MEDICAL, INC.PY2024: IlluminOss Medical, Inc.. Matching identifiers support a bounded record comparison; a label difference would be reported as unresolved rather than treated as a corporate event.
Subscribe to this company's source-bounded update feed It publishes only identifier-matched CMS release comparisons, never inferred company events.
General Payments: PY2023 vs PY2024
Annual CMS-reported totals for this company, not an all-category Open Payments total
- PY2023
- $148,286.15
- PY2024
- $168,851.78
What the Data Shows for IlluminOss Medical, Inc.
Rank #894 of 1,925 companies in CMS Open Payments for 2024 belongs to IlluminOss Medical, Inc., which reported $293,677.78 across 486 transactions to 469 recipients - a comparatively small 0.0% slice of all industry payments reported nationwide for the year. Averages work out to $604.28 per transaction and $626.18 per recipient.
The 5-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Honoraria" at $57.6K, accounting for 34.1% of this company's General Payments and 22 transactions.
General Payment Breakdown by Type
Across 5 types of general payments, IlluminOss Medical, Inc.'s largest category was "Honoraria" at $57.6K - 34.1% of General Payments.
IlluminOss Medical, Inc. reports 5 general-payment categories - the top three are Honoraria (34.1%), Consulting Fee (32.2%), and Education (16.6%). The remaining 2 categories make up 17.1% of this company's reported general-payment total. That multi-category mix is the kind of profile single-category reporters cannot show.
How IlluminOss Medical, Inc. divides its payments
Ranked by total dollars reported per category
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Honoraria | $57.6K | 22 | 34.1% |
| Consulting Fee | $54.3K | 75 | 32.2% |
| Education | $28.0K | 7 | 16.6% |
| Food and Beverage | $23.0K | 360 | 13.6% |
| Travel and Lodging | $5.9K | 5 | 3.5% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $69,890.81 (41.4%) of $168,851.78 in this company's General Payments records across 294 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for IlluminOss Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
William Hartman Harvin
$29,681.60 across 15 reported transactions
- 2
Kyle Mobley
$13,392.38 across 4 reported transactions
- 3
Christopher Born
$10,790.00 across 3 reported transactions
- 4
James Daniel Hlavacek
$8,125.47 across 7 reported transactions
- 5
Brooke M. Crawford
$7,901.36 across 7 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as IlluminOss Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about IlluminOss Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with IlluminOss Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Nexxt Spine LLC
$292.8K 358 recipients
Compare payment profiles
Evoke Pharma, Inc.
$292.8K 3,417 recipients
Compare payment profiles
Exo Imaging, Inc.
$292.7K 175 recipients
Compare payment profiles
Episurf Medical, Inc.
$295.1K 34 recipients
Compare payment profiles
Intra-Sana Laboratories
$291.3K 3,142 recipients
Compare payment profiles
Data sourced from CMS Open Payments (Physician Payments Sunshine Act). See our methodology for details. Retrieved and formatted by PlainPharmaWatch
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.